Thalomid, Thalidomide
Thalomid, Thalidomide Newswire

Thalomid, Thalidomide Newswire

Comprehensive Real-Time News Feed for Thalomid, Thalidomide (generic).

Results 1 - 20 of 391 in Thalomid, Thalidomide (generic)

  1. Celgene says patent-fighting hedge fund manager wants to short its sharesRead the original story

    6 hrs ago | Reuters

    Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and Trademark Office on Tuesday to sanction Bass and others behind the group by throwing out its challenges to Celgene's patents.

    Comment?

  2. Protective effects of thalidomide on pulmonary injuries in a rat model of paraquat intoxicationRead the original story

    Tuesday | Journal of Inflammation

    Department of Emergency Medicine, The Second Hospital of Jilin University, No. 218 Ziqiang Street, Changchun 130041, Nanguan District, People's Republic of China Department of Cardiovascular Surgery, The Second Hospital of Jilin University, No.

    Comment?

  3. Plaintiffs, GSK Disagree Over Thalidomide Client InterviewsRead the original story w/Photo

    May 28, 2015 | Law.com

    While GlaxoSmithKline and the plaintiffs firm leading dozens of thalidomide injury suits against the company have largely agreed on the dismissal of 31 of those claims against GSK, the pharmaceutical company is now diverging from the law firm on an attorney-client privilege issue before the Third Circuit.

    Comment?

  4. Steroid-refractory chronic GVHD trial results 'overestimate' treatment efficacyRead the original story w/Photo

    Friday Jul 24 | Medical News

    Trial results for patients with steroid-refractory chronic graft versus host have overestimated the efficacies of treatments, suggests a meta-analysis published in The Lancet Haematology . However, the authors believe that future trials could reduce this bias by following a 61-point checklist of guidelines, based on the US National Institute of Health consensus project on SR-cGVHD in 2006.

    Comment?

  5. Disability visibility: 'Cripfest' reclaims the wordRead the original story w/Photo

    Thursday Jul 23 | The Brooklyn Paper

    Crippled and proud: Mat Fraser, who has organized a showcase of disabled artists called "CripFest" says he is proud to call himself a cripple. A group of comedians, dancers, and other performers with disabilities will converge on Fort Greene on July 25 for an all-day festival that celebrates their talents.

    Comment?

  6. Kim Kardashian is now hawking controversial pregnancy drugRead the original story w/Photo

    Thursday Jul 23 | She Knows

    Monica Beyer is a mom of four and has been writing professionally since 2000, when her first book, Baby Talk , was published. Her main area of interest is attachment parenting and all that goes with it, including breastfeeding, co-sleepin... And the reality star apparently trusts the reports - she shared an Instagram photo that could be construed as an endorsement.

    Comment?

  7. Third Circuit Greenlights Thalidomide Client InterviewsRead the original story w/Photo

    Jun 3, 2015 | Law.com

    The Third Circuit has refused Hagens Berman Sobol Shapiro's request to stop court interviews of 31 firm clients inquiring whether they are willingly dismissing their thalidomide claims against GlaxoSmithKline and others.

    Comment?

  8. Hagens Berman Fights Court Interviews of Thalidomide ClientsRead the original story w/Photo

    May 20, 2015 | Law.com

    A federal judge has denied Hagens Berman Sobol Shapiro's request to stay interviews of 31 of the firm's clients to determine whether they are knowingly dismissing their thalidomide-injury cases, but not before the law firm filed a petition seeking a writ of mandamus with the Third Circuit seeking the higher court's intervention.

    Comment?

  9. Successful treatment of bleeding gastro-intestinal angiodysplasia in...Read the original story

    Wednesday Jul 22 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. Hereditary haemorrhagic telangiectasia is an autosomal dominant disorder characterised by epistaxis, cutaneous telangiectasia and visceral arterio-venous malformations .

    Comment?

  10. GlaxoSmithKline Files Motion To Consolidate Zofran Litigation In PhiladelphiaRead the original story w/Photo

    Tuesday Jul 21 | JD Supra

    Zofran was developed to prevent nausea and vomiting caused by cancer chemotherapy. However, doctors prescribed it for the treatment of morning sickness in pregnant women.

    Comment?

  11. BWW Exclusive: Mat Fraser Talks Cripfest, American Horror Story: Freak Show & MoreRead the original story w/Photo

    Monday Jul 20 | BroadwayWorld.com

    Today we are talking to a spectacularly talented and accomplished performer who has excelled in many mediums as an actor onstage and onscreen as well as a high-profile proponent and figurehead for those with disabilities, the charming and thoughtful Mat Fraser. Opening up about curating this week's upcoming event highlighting many performers with disabilities titled CRIPFEST, Fraser touches upon the importance of the 25th anniversary of the Americans With Disabilities Act and what attendees can expect from the wide range of entertainment on hand at the event.

    Comment?

  12. Kim Kardashian is pitching a morning sickness drugRead the original story w/Photo

    Monday Jul 20 | New York Daily News

    The reality TV star posted a picture of herself on her Instagram feed on Sunday holding up a bottle of Diclegis, a prescription medication that, she claimed, made her feel "a lot better" as she carries her second child. Strange bedfellows: Diclegis, which has been on the market since 2003, was once sold under the name Bendectin and was pulled from the market in 1983 because it was associated with birth defects.

    Comment?

  13. Tiny beating human heart made from scratchRead the original story

    Tuesday Jul 14 | New Scientist

    In the dish, they're just tiny dots. But look through a microscope and you can see minute beating human hearts, each sporting its own ventricle-like chamber.

    Comment?

  14. How researchers can grow tiny, beating hearts in a labratoryRead the original story w/Photo

    Saturday Jul 18 | Silicon Alley Insider

    Now, scientists have created a system that allows them to successfully grow tiny beating "hearts" from stem cells, complete with microscopic chambers. Although this isn't the first time that miniaturized hearts have been grown in a lab, this newly developed method is an improvement on earlier techniques due to the addition of physical cues that help prompt and guide cell fate during the differentiation process, meaning structure and cell organization can be controlled to a greater extent.

    Comment?

  15. Third Circuit Greenlights Thalidomide Client InterviewsRead the original story w/Photo

    Jun 3, 2015 | Law.com

    The Third Circuit has refused Hagens Berman Sobol Shapiro's request to stop court interviews of 31 firm clients inquiring whether they are willingly dismissing their thalidomide claims against GlaxoSmithKline and others.

    Comment?

  16. A Human Heart-on-a-Chip Screens Drugs for Potential Benefit, HarmRead the original story

    Thursday Jul 16 | Newswise

    Researchers at UC Berkeley and Gladstone Institutes have shown that human induced pluripotent stem cells can differentiate and self-organize into cardiac microchambers when spatially confined. The center shows heart muscle cells while the perimeter shows a type of connective tissue that attaches to the surface and holds the microchamber to the culture dish.

    Comment?

  17. Hagens Berman Fights Court Interviews of Thalidomide ClientsRead the original story w/Photo

    May 20, 2015 | Law.com

    A federal judge has denied Hagens Berman Sobol Shapiro's request to stay interviews of 31 of the firm's clients to determine whether they are knowingly dismissing their thalidomide-injury cases, but not before the law firm filed a petition seeking a writ of mandamus with the Third Circuit seeking the higher court's intervention.

    Comment?

  18. Choosing the Ideal Lymphoma RegimensRead the original story

    Thursday Jul 16 | The American Journal of Managed Care

    At the annual meeting of the American Society of Clinical Oncology in Chicago, physicians introduced some new lymphoma treatments as they described their personal experience with using them during the session, "Incorporating Novel Agents Into Lymphoma Therapy: Value in Everyday Practice." While a number of active therapies are available to treat lymphoma, several new agents have been approved for this setting.

    Comment?

  19. OP-ED | Expertise? Some People Actually Do Know More About Certain Topics Than OthersRead the original story w/Photo

    Apr 29, 2015 | Ctnewsjunkie.com

    If I had known how complicated my path to teaching would be when I decided to change careers 25 years ago, I might not be a teacher today. One bachelor's degree earned, a thesis shy of a master's degree in business, and six years into a career in public relations, I decided I wanted to teach high school English.

    Comment?

  20. Plaintiffs, GSK Disagree Over Thalidomide Client InterviewsRead the original story w/Photo

    May 28, 2015 | Law.com

    While GlaxoSmithKline and the plaintiffs firm leading dozens of thalidomide injury suits against the company have largely agreed on the dismissal of 31 of those claims against GSK, the pharmaceutical company is now diverging from the law firm on an attorney-client privilege issue before the Third Circuit.

    Comment?